Holocene Advisors’s Oak Street Health, Inc. OSH Stock Holding History

Holocene Advisors’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,706	Closed	-$1.07M	–	896
2023 Q1	$1.07M	Sell	27,706 -3,316,162	-99%	-$107M	0.01%	575
2022 Q4	$71.9M	Buy	3,343,868 +54,805	+2%	+$1.15M	0.44%	76
2022 Q3	$80.6M	Sell	3,289,063 -1,642,965	-33%	-$43.5M	0.52%	65
2022 Q2	$81.1M	Buy	4,932,028 +1,136,154	+30%	+$22.1M	0.49%	65
2022 Q1	$102M	Buy	3,795,874 +2,386,462	+169%	+$50.3M	0.53%	64
2021 Q4	$46.7M	Buy	1,409,412 +976,572	+226%	+$37M	0.24%	122
2021 Q3	$18.4M	Sell	432,840 -440,715	-50%	-$23.7M	0.1%	205
2021 Q2	$51.2M	Sell	873,555 -210,163	-19%	-$12.5M	0.29%	120
2021 Q1	$58.8M	Buy	1,083,718 +870,978	+409%	+$48.5M	0.37%	86
2020 Q4	$13M	Buy	212,740 +206,740	+3,446%	+$10.8M	0.08%	237
2020 Q3	$321K	Buy	+6,000	New	+$269K	﹤0.01%	618

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Holocene Advisors's OSH Position: Q2 2023 in Review

Holocene Advisors sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 27,706 shares — an estimated $1.07M sold.

Holocene Advisors first reported a position in OSH in Q3 2020 and held it in 11 quarters. The position peaked at $102M in Q1 2022. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Holocene Advisors reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Holocene Advisors sold 27,706 Oak Street Health, Inc. shares in Q2 2023, an estimated $1.07M.
Holocene Advisors first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 11 quarters.
Holocene Advisors's Oak Street Health, Inc. position peaked at $102M in Q1 2022.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Holocene Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.